T. Stanes gets a Patent for a Novel Microbial Technology

T. Stanes gets a Patent for a Novel Microbial Technology
Planify Author
Author

Planify Author

Financial Analyst Intern
Publish Date15 August 2023
Reading time2 Min

Share on Social Links

Category

StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore

T. Stanes and Company Limited has received a patent grant from the Indian Patent Office (IPO) for their patent application titled "Method and formulation of a novel yeast with plant growth-promoting activities." This patent enables the production of an innovative multifunctional microbial product, marking another significant achievement in T. Stanes' growing intellectual property portfolio.

T. Stanes & Co. Ltd., a specialized provider of organic inputs for agriculture, has successfully developed a groundbreaking microbial-based product known as 5MlN. This unique product showcases a range of functions, including swift nutrient accessibility, antagonistic properties, induction of disease resistance, and enhanced plant health. 5MlN contains yeast as its active component and is crafted using a patented innovative production and formulation technology. Leveraging advanced fermentation techniques, this superior biological product offers distinct qualities that set it apart.

Tags

Unlisted SharesPre-IPOInvestmentStock MarketFinance

Stay Connected, Stay Informed –

Join Our

WhatsApp

Channel!

Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.